These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 11967952)
1. Differentiation and stromal-induced growth promotion of murine prostatic tumors. Salm SN; Takao T; Tsujimura A; Coetzee S; Moscatelli D; Wilson EL Prostate; 2002 May; 51(3):175-88. PubMed ID: 11967952 [TBL] [Abstract][Full Text] [Related]
2. Generation of active TGF-beta by prostatic cell cocultures using novel basal and luminal prostatic epithelial cell lines. Salm SN; Koikawa Y; Ogilvie V; Tsujimura A; Coetzee S; Moscatelli D; Moore E; Lepor H; Shapiro E; Sun TT; Wilson EL J Cell Physiol; 2000 Jul; 184(1):70-9. PubMed ID: 10825235 [TBL] [Abstract][Full Text] [Related]
3. Androgen and prostatic stroma. Niu YJ; Ma TX; Zhang J; Xu Y; Han RF; Sun G Asian J Androl; 2003 Mar; 5(1):19-26. PubMed ID: 12646998 [TBL] [Abstract][Full Text] [Related]
4. Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model. Tuxhorn JA; McAlhany SJ; Dang TD; Ayala GE; Rowley DR Cancer Res; 2002 Jun; 62(11):3298-307. PubMed ID: 12036948 [TBL] [Abstract][Full Text] [Related]
5. Development and characterization of DP-153, a nontumorigenic prostatic cell line that undergoes malignant transformation by expression of dominant-negative transforming growth factor beta receptor type II. Song K; Cornelius SC; Danielpour D Cancer Res; 2003 Aug; 63(15):4358-67. PubMed ID: 12907605 [TBL] [Abstract][Full Text] [Related]
6. Promotion of angiogenesis by ps20 in the differential reactive stroma prostate cancer xenograft model. McAlhany SJ; Ressler SJ; Larsen M; Tuxhorn JA; Yang F; Dang TD; Rowley DR Cancer Res; 2003 Sep; 63(18):5859-65. PubMed ID: 14522910 [TBL] [Abstract][Full Text] [Related]
7. Malignant transformation in a nontumorigenic human prostatic epithelial cell line. Hayward SW; Wang Y; Cao M; Hom YK; Zhang B; Grossfeld GD; Sudilovsky D; Cunha GR Cancer Res; 2001 Nov; 61(22):8135-42. PubMed ID: 11719442 [TBL] [Abstract][Full Text] [Related]
8. Stromal/epithelial interactions of murine prostatic cell lines in vivo: a model for benign prostatic hyperplasia and the effect of doxazosin on tissue size. Takao T; Tsujimura A; Coetzee S; Salm SN; Lepor H; Shapiro E; Moscatelli D; Wilson EL Prostate; 2003 Jan; 54(1):17-24. PubMed ID: 12481251 [TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-beta is an autocrine mitogen for a novel androgen-responsive murine prostatic smooth muscle cell line, PSMC1. Salm SN; Koikawa Y; Ogilvie V; Tsujimura A; Coetzee S; Moscatelli D; Moore E; Lepor H; Shapiro E; Sun TT; Wilson EL J Cell Physiol; 2000 Dec; 185(3):416-24. PubMed ID: 11056012 [TBL] [Abstract][Full Text] [Related]
10. Induction of smooth muscle cell phenotype in cultured human prostatic stromal cells. Peehl DM; Sellers RG Exp Cell Res; 1997 May; 232(2):208-15. PubMed ID: 9168795 [TBL] [Abstract][Full Text] [Related]
11. Modulation of phenotype of human prostatic stromal cells by transforming growth factor-betas. Hisataki T; Itoh N; Suzuki K; Takahashi A; Masumori N; Tohse N; Ohmori Y; Yamada S; Tsukamoto T Prostate; 2004 Feb; 58(2):174-82. PubMed ID: 14716743 [TBL] [Abstract][Full Text] [Related]
12. A conditionally immortalized cell line model for the study of human prostatic epithelial cell differentiation. Daly-Burns B; Alam TN; Mackay A; Clark J; Shepherd CJ; Rizzo S; Tatoud R; O'Hare MJ; Masters JR; Hudson DL Differentiation; 2007 Jan; 75(1):35-48. PubMed ID: 17244020 [TBL] [Abstract][Full Text] [Related]
13. Human cell lines as an in vitro/in vivo model for prostate carcinogenesis and progression. Webber MM; Quader ST; Kleinman HK; Bello-DeOcampo D; Storto PD; Bice G; DeMendonca-Calaca W; Williams DE Prostate; 2001 Apr; 47(1):1-13. PubMed ID: 11304724 [TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma. Yang F; Strand DW; Rowley DR Oncogene; 2008 Jan; 27(4):450-9. PubMed ID: 17637743 [TBL] [Abstract][Full Text] [Related]
15. Development and characterization of nontumorigenic and tumorigenic epithelial cell lines from rat dorsal-lateral prostate. Danielpour D; Kadomatsu K; Anzano MA; Smith JM; Sporn MB Cancer Res; 1994 Jul; 54(13):3413-21. PubMed ID: 8012960 [TBL] [Abstract][Full Text] [Related]
16. Sex steroids have differential effects on growth and gene expression in primary human prostatic epithelial cell cultures derived from the peripheral versus transition zones. Kirschenbaum A; Liu XH; Yao S; Narla G; Friedman SL; Martignetti JA; Levine AC Carcinogenesis; 2006 Feb; 27(2):216-24. PubMed ID: 16123118 [TBL] [Abstract][Full Text] [Related]
17. Cotargeting tumor and stroma in a novel chimeric tumor model involving the growth of both human prostate cancer and bone stromal cells. Hsieh CL; Gardner TA; Miao L; Balian G; Chung LW Cancer Gene Ther; 2004 Feb; 11(2):148-55. PubMed ID: 14695756 [TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor binding protein-3 (IGFBP-3) in the prostate and in prostate cancer: local production, distribution and secretion pattern indicate a role in stromal-epithelial interaction. Massoner P; Haag P; Seifarth C; Jurgeit A; Rogatsch H; Doppler W; Bartsch G; Klocker H Prostate; 2008 Aug; 68(11):1165-78. PubMed ID: 18459102 [TBL] [Abstract][Full Text] [Related]
19. In vitro modelling of epithelial and stromal interactions in non-malignant and malignant prostates. Lang SH; Stower M; Maitland NJ Br J Cancer; 2000 Feb; 82(4):990-7. PubMed ID: 10732776 [TBL] [Abstract][Full Text] [Related]
20. Tumor-host interaction mediates the regression of BK virus-induced vascular tumors in mice: involvement of transforming growth factor-beta1. Corallini A; Possati L; Trabanelli C; Giraudo E; Rocchetti R; Talevi S; Caputo A; Bussolino F; Barbanti-Brodano G Carcinogenesis; 2003 Sep; 24(9):1435-44. PubMed ID: 12844479 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]